Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C

PHASE3CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Chronic Hepatitis C
Interventions
DRUG

epoetin beta (NeoRecormon®)

• Prescription of the epoetin beta : when blood concentration of hemoglobin is lower or equal to 12 g/dL in male or lower or equal to 11 g/dL in female

Trial Locations (37)

13616

H Aix en Provence, Aix-en-Provence

28100

H Dreux, Dreux

45100

H Orléans, Orléans

49933

UH Angers, Angers

63009

UH Clermont Ferrand, Clermont-Ferrand

72000

H Le Mans, Le Mans

85925

H La Roche sur Yon, La Roche-sur-Yon

87042

UH Limoges, Limoges

94010

H Créteil, Créteil

84 902

H Avignon, Avignon

38 317

H Bourgoin-Jallieu, Bourgoin

29 609

UH Brest, Brest

14 033

UH Caen, Caen

36 000

H Châteauroux, Châteauroux

91 106

H Corbeil-Essonnes, Corbeil-Essonnes

60 100

H Creil, Creil

21 079

UH Dijon, Dijon

57 804

H Freyming-Merlebach, Freyming-Merlebach

06 130

H Grasse, Grasse

38 043

UH Grenoble, Grenoble

69 288

UH Lyon, Lyon

13 285

H Saint-Joseph, Marseille

82 013

H Montauban, Montauban

26 200

H montélimar, Montélimar

34 295

UH Montpellier, Montpellier

44 800

UH Nantes, Nantes

75 020

H Tenon, Paris

75 571

H saint-Antoine, Paris

64 011

H Pau, Pau

86 020

UH Poitiers, Poitiers

35 043

UH Rennes, Rennes

76 031

UH Rouen, Rouen

52 115

H Saint-Dizier, Saint-Dizier

06721

Arnault Tzanck Institute, Saint-Laurent-du-Var

31 059

UH Toulouse, Toulouse

59 208

H Tourcoing, Tourcoing

37 170

UH Tours, Tours

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT00262379 - Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C | Biotech Hunter | Biotech Hunter